160 related articles for article (PubMed ID: 16952136)
41. Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis.
Arcuri HA; Borges JC; Fonseca IO; Pereira JH; Neto JR; Basso LA; Santos DS; de Azevedo WF
Proteins; 2008 Aug; 72(2):720-30. PubMed ID: 18260104
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of 7,8-diaminopelargonic acid aminotransferase from Mycobacterium tuberculosis by chiral and achiral anologs of its substrate: biological implications.
Mann S; Colliandre L; Labesse G; Ploux O
Biochimie; 2009 Jul; 91(7):826-34. PubMed ID: 19345718
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase.
Nurbo J; Roos AK; Muthas D; Wahlström E; Ericsson DJ; Lundstedt T; Unge T; Karlén A
J Pept Sci; 2007 Dec; 13(12):822-32. PubMed ID: 17918768
[TBL] [Abstract][Full Text] [Related]
44. (1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases.
Frederickson M; Roszak AW; Coggins JR; Lapthorn AJ; Abell C
Org Biomol Chem; 2004 Jun; 2(11):1592-6. PubMed ID: 15162210
[TBL] [Abstract][Full Text] [Related]
45. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
46. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
47. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
[TBL] [Abstract][Full Text] [Related]
48. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
49. Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?
Holzgrabe U
ChemMedChem; 2009 Jul; 4(7):1051-3. PubMed ID: 19462395
[TBL] [Abstract][Full Text] [Related]
50. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.
Mascarello A; Chiaradia LD; Vernal J; Villarino A; Guido RV; Perizzolo P; Poirier V; Wong D; Martins PG; Nunes RJ; Yunes RA; Andricopulo AD; Av-Gay Y; Terenzi H
Bioorg Med Chem; 2010 Jun; 18(11):3783-9. PubMed ID: 20462762
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
53. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Subba Rao G; Vijayakrishnan R; Kumar M
Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
[TBL] [Abstract][Full Text] [Related]
54. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
Vanheusden V; Munier-Lehmann H; Froeyen M; Busson R; Rozenski J; Herdewijn P; Van Calenbergh S
J Med Chem; 2004 Dec; 47(25):6187-94. PubMed ID: 15566289
[TBL] [Abstract][Full Text] [Related]
55. Molecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosis.
Ruggiero A; Marchant J; Squeglia F; Makarov V; De Simone A; Berisio R
J Biomol Struct Dyn; 2013; 31(2):195-205. PubMed ID: 22831279
[TBL] [Abstract][Full Text] [Related]
56. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
57. Parallel solid-phase synthesis and evaluation of inhibitors of Streptomyces coelicolor type II dehydroquinase.
González-Bello C; Lence E; Toscano MD; Castedo L; Coggins JR; Abell C
J Med Chem; 2003 Dec; 46(26):5735-44. PubMed ID: 14667226
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of new inhibitors of UDP-Galf transferase--a key enzyme in M. tuberculosis cell wall biosynthesis.
Cren S; Gurcha SS; Blake AJ; Besra GS; Thomas NR
Org Biomol Chem; 2004 Sep; 2(17):2418-20. PubMed ID: 15326520
[TBL] [Abstract][Full Text] [Related]
59. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol.
Kremer L; de Chastellier C; Dobson G; Gibson KJ; Bifani P; Balor S; Gorvel JP; Locht C; Minnikin DE; Besra GS
Mol Microbiol; 2005 Aug; 57(4):1113-26. PubMed ID: 16091048
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
